Brainstorm Diagnostics
PrivateLast Round
Seed
Dec 14, 2021
Company Overview
Brainstorm Diagnostics operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Seed round in December 2021.
Brainstorm Diagnostics is a biotechnology company developing a blood-based biomarker test for the early diagnosis and prognosis of traumatic brain injury.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brainstorm Diagnostics Comparables
Compare Brainstorm Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| bioMérieux | 74% | |
| Abbott Laboratories | 72% | |
| Quanterix Corporation | 63% |
For institutional investors. Book with your work email.
Brainstorm Diagnostics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Brainstorm Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Penn Center for Innovation | Seed |
Brainstorm Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Brainstorm Diagnostics's valuation, stock price, and market status.
Is Brainstorm Diagnostics a public or private company?
Brainstorm Diagnostics is a private company.
What is the current stock price of Brainstorm Diagnostics?
Brainstorm Diagnostics is a private company, so its shares have no public market price. Caplight tracks Brainstorm Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Brainstorm Diagnostics worth (valuation)?
Valuation information for Brainstorm Diagnostics is not publicly available.
Can I buy Brainstorm Diagnostics stock?
Brainstorm Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Brainstorm Diagnostics's last funding round?
Brainstorm Diagnostics's most recent funding round was Seed on December 14, 2021.
Who are the main investors in Brainstorm Diagnostics?
Key investors in Brainstorm Diagnostics include Penn Center for Innovation.
Will Brainstorm Diagnostics IPO soon?
No public IPO plans have been announced for Brainstorm Diagnostics.
How can I track Brainstorm Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Brainstorm Diagnostics's shares on secondary markets.